Rawcliffe Adrian sold WVE
December 8, 2025 · Form 4 insider transaction
Rawcliffe Adrian sold 42,000 shares of Wave Life Sciences, Inc. at $15.00 per share, a transaction worth $630.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
42,000
Price
$15.00
Total value
$630.0K
InsiderRawcliffe Adrian
RoleDirector
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateDecember 8, 2025
Filing dateDecember 10, 2025
Shares owned after12,700
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2025.